Promise Proteomics is a pioneer and expert in mass spectrometry-based quantification methods development and in bioproduction of Stable Isotope Labeled (SIL) monoclonal antibodies (mAbs).
New generation of biotherapies monitoring by mass spectrometry
mAbXmise is an innovation born from the combination of Promise Proteomics’ recognized expertise in mass spectrometry and its unique know-how in the production of internal standards for proteins assays. Today this innovative range is available in clinical practice to assist healthcare professionals in their decision making.
Three kits available: Oncology, Inflammation, Transplantation
Each kit includes:
96-well plate coated with stable labeled mAbs (internal standards)
Relevant buffers and solutions
This product is for research use only and is not intended for diagnostic or therapeutic use.
*Allumiqs distributes Promise Proteomics products exclusively in Canada and the United States. If you are not located in these regions, please visit the Promise Proteomics website for more information.